Outcomes of Transsphenoidal Surgery in Growth Hormone-Secreting Pituitary Adenomas
Growth hormone (GH)-secreting pituitary adenomas (PA) make up 15 to 20% of total amount of hormonally active adenomas. In addition to acromegaly and gigantism, these tumors cause deep metabolic disturbances. Its systemic impact leads to increased mortality ratio of 1.32 compared with general populat...
Main Authors: | Oleksandr Voznyak, Andrii Lytvynenko, Oleg Maydannyk, Roman Ilyuk, Yaroslav Zinkevych, Nazarii Hryniv |
---|---|
Format: | Article |
Language: | English |
Published: |
Thieme Medical Publishers, Inc.
2021-03-01
|
Series: | Indian Journal of Neurosurgery |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1726134 |
Similar Items
-
Possibilities of endoscopic endonasal transsphenoidal surgery in treatment of growth-hormone pituitary adenomas
by: Ruslan V. Aksyonov, et al.
Published: (2021-06-01) -
The Therapeutic Effect of Endoscopic Tumor Resection on Acromegalic Cardiomegaly in Patients With Pituitary Adenoma
by: Kaveh Ebrahimzadeh, et al.
Published: (2020-01-01) -
Reappraisal of microscopic microsurgical transsphenoidal surgery for GH-secreting pituitary macroadenoma in patients with acromegaly: Historical data from Vietnam (2010–2013)
by: Ngo Manh Hung, et al.
Published: (2020-12-01) -
Microscopic Transsphenoidal Surgery for Pituitary Adenomas in Children and Adolescents
by: Masoud Shirvani, et al.
Published: (2015-12-01) -
Pituitary Adenomas: From Diagnosis to Therapeutics
by: Samridhi Banskota, et al.
Published: (2021-04-01)